GOVIX
Price
$23.34
Change
+$0.32 (+1.39%)
Updated
Jan 14 closing price
Net Assets
1.15B
RSNYX
Price
$55.41
Change
+$0.63 (+1.15%)
Updated
Jan 14 closing price
Net Assets
483.9M
Interact to see
Advertisement

GOVIX vs RSNYX

Header iconGOVIX vs RSNYX Comparison
Open Charts GOVIX vs RSNYXBanner chart's image
GMO Resources IV
Price$23.34
Change+$0.32 (+1.39%)
VolumeN/A
Net Assets1.15B
Victory Global Energy Transition Y
Price$55.41
Change+$0.63 (+1.15%)
VolumeN/A
Net Assets483.9M
GOVIX vs RSNYX Comparison Chart in %
View a ticker or compare two or three
VS
GOVIX vs. RSNYX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOVIX is a Hold and RSNYX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GOVIX has more cash in the bank: 1.15B vs. RSNYX (484M). RSNYX (4.39) and GOVIX (4.38) have matching dividends . GOVIX was incepted earlier than RSNYX: GOVIX (13 years) vs RSNYX (19 years). RSNYX (1.21) is less costly to investors than GOVIX (0.67). RSNYX is a more actively managed with annual turnover of: 57.00 vs. GOVIX (48.00). RSNYX has a lower initial minimum investment than GOVIX: RSNYX (1000000) vs GOVIX (125000000). RSNYX annual gain was more profitable for investors over the last year : 73.89 vs. GOVIX (28.50). RSNYX return over 5 years is better than : 311.68 vs. GOVIX (3.89).
GOVIXRSNYXGOVIX / RSNYX
Total Expense Ratio0.671.1558%
Annual Report Gross Expense Ratio0.671.2155%
Fund Existence13 years19 years-
Gain YTD8.5085.623151%
Front LoadN/AN/A-
Min. Initial Investment125000000100000012,500%
Min. Initial Investment IRAN/AN/A-
Net Assets1.15B484M238%
Annual Yield % from dividends4.384.39100%
Returns for 1 year28.5073.8939%
Returns for 3 years-1.9480.15-2%
Returns for 5 years3.89311.681%
Returns for 10 years227.70364.1163%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTGX85.233.87
+4.76%
Protagonist Therapeutics
MFC37.330.54
+1.47%
Manulife Financial Corp
UIS3.270.02
+0.62%
Unisys Corp
OLPX1.64-0.01
-0.61%
Olaplex Holdings
BTOC0.53N/A
-0.64%
Armlogi Holding Corp